Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 11, 2014, Pages 1959-1966

  Zhang, Z ^a,b   Liu, M ^c   Wang, Y ^b   Pang, Y ^b   Kam, K M ^d   Zhao, Y ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Liaoning Provincial Center for Disease Control and Prevention   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BIOLOGICAL MARKER; CAPREOMYCIN; KANAMYCIN; TUBERCULOSTATIC AGENT;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; CROSS RESISTANCE; GENE LOCUS; GENE MUTATION; GENOTYPE; GEOGRAPHIC ORIGIN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PROMOTER REGION; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; POINT MUTATION;

AMIKACIN; ANTITUBERCULAR AGENTS; CAPREOMYCIN; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HUMANS; KANAMYCIN; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POINT MUTATION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84911008007     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2144-5     Document Type: Article

References (33)

1. Dye C (2009) Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat Rev Microbiol 7(1):81–87
2. Almeida Da Silva PE, Palomino JC (2011) Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J Antimicrob Chemother 66(7):1417–1430
3. World Health Organization (WHO) (2008) Anti-tuberculosis drug resistance in the world. Report no. 4. WHO, WHO/HTM/TB/2008.394
4. Falzon D, Gandhi N, Migliori GB, Sotgiu G, Cox HS, Holtz TH et al (2013) Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J 42(1):156–168
5. Raviglione MC, Smith IM (2007) XDR tuberculosis—implications for global public health. N Engl J Med 356(7):656–659
6. Balasingham SV, Davidsen T, Szpinda I, Frye SA, Tønjum T (2009) Molecular diagnostics in tuberculosis: basis and implications for therapy. Mol Diagn Ther 13(3):137–151
7. Richter E, Rüsch-Gerdes S, Hillemann D (2009) Drug-susceptibility testing in TB: current status and future prospects. Expert Rev Respir Med 3(5):497–510
8. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S (2005) Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 43(8):3699–3703
9. Ramaswamy S, Musser JM (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79(1):3–29
10. Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC (2012) Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One 7(3):e33275
11. Jugheli L, Bzekalava N, de Rijk P, Fissette K, Portaels F, Rigouts L (2009) High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob Agents Chemother 53(12):5064–5068
12. Du Q, Dai G, Long Q, Yu X, Dong L, Huang H et al (2013) Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China. Diagn Microbiol Infect Dis 77(2):138–142
13. Maus CE, Plikaytis BB, Shinnick TM (2005) Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 49(8):3192–3197
14. Zaunbrecher MA, Sikes RD Jr, Metchock B, Shinnick TM, Posey JE (2009) Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 106(47):20004–20009
15. Engström A, Perskvist N, Werngren J, Hoffner SE, Juréen P (2011) Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 66(6):1247–1254
16. Maus CE, Plikaytis BB, Shinnick TM (2005) Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 49(2):571–577
17. Tsukamura M, Mizuno S (1975) Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis. J Gen Microbiol 88(2):269–274
18. Pang Y, Zhou Y, Zhao B, Liu G, Jiang G, Xia H et al (2012) Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One 7(3):e32976
19. Zhang Z, Pang Y, Wang Y, Liu C, Zhao Y (2014) Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China. Int J Antimicrob Agents 43(3):231–235
20. Parwati I, van Crevel R, van Soolingen D (2010) Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis 10(2):103–111
21. Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G et al (2012) National survey of drug-resistant tuberculosis in China. N Engl J Med 366(23):2161–2170
22. Pang Y, Lu J, Wang Y, Song Y, Wang S, Zhao Y (2013) Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis. Antimicrob Agents Chemother 57(2):893–900
23. World Health Organization (WHO) (2009) Guidelines for surveillance of drug resistance in tuberculosis. Fourth edition (and supplementary materials). WHO, WHO/HTM/TB/2009.422
24. Pang Y, Zhou Y, Wang S, Lu J, Lu B, He G et al (2011) A novel method based on high resolution melting (HRM) analysis for MIRU-VNTR genotyping of Mycobacterium tuberculosis. J Microbiol Methods 86(3):291–297
25. Dalton T, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, Cho SN et al (2012) Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet 380(9851):1406–1417
26. Duong DA, Nguyen TH, Nguyen TN, Dai VH, Dang TM, Vo SK et al (2009) Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam. Antimicrob Agents Chemother 53(11):4835–4839
27. Rindi L, Lari N, Cuccu B, Garzelli C (2009) Evolutionary pathway of the Beijing lineage of Mycobacterium tuberculosis based on genomic deletions and mutT genes polymorphisms. Infect Genet Evol 9(1):48–53
28. Ebrahimi-Rad M, Bifani P, Martin C, Kremer K, Samper S, Rauzier J et al (2003) Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis 9(7):838–845
29. Zhao LL, Chen Y, Liu HC, Xia Q, Wu XC, Sun Q et al (2014) Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China. Antimicrob Agents Chemother 58(4):1997–2005
30. Alangaden GJ, Kreiswirth BN, Aouad A, Khetarpal M, Igno FR, Moghazeh SL et al (1998) Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 42(5):1295–1297
31. Krüüner A, Jureen P, Levina K, Ghebremichael S, Hoffner S (2003) Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 47(9):2971–2973
32. Jugheli L, Rigouts L, Shamputa IC, Bram de Rijk W, Portaels F (2008) High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia. Int J Tuber Lung Dis 12(5):561–566
33. Yuan X, Zhang T, Kawakami K, Zhu J, Li H, Lei J et al (2012) Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China. J Clin Microbiol 50(7):2404–2413